Pyrophyte Acquisition Corp. 8-K

What Happened
Pyrophyte Acquisition Corp. announced that at an Extraordinary General Meeting its shareholders approved an Extension Amendment and, on April 28, 2026, the company entered into new financing with its sponsor, Pyrophyte Acquisition LLC. The company issued a non‑interest bearing promissory note (the “Fourth Extension Note”) to the sponsor with principal up to $1,200,000, payable at the earlier of the closing of an initial business combination or the company’s liquidation. The company also amended and restated its Working Capital Convertible Promissory Note to extend its maturity to the earlier of the Extended Date and the effective date of an initial business combination and to allow borrowings for ongoing expenses.

Key Details

• Fourth Extension Note: up to $1,200,000 principal, no interest, repayable upon consummation of an initial business combination or liquidation; if no combination by the Extended Date, repayment limited to funds outside the Trust Account or may be forgiven.
• Working Capital Convertible Promissory Note: maturity extended to the earlier of the Extended Date and the effective date of an initial business combination; sponsor may convert up to $1,500,000 outstanding under the note into warrants at $1.00 per warrant. Each warrant would allow purchase of one Class A ordinary share at $11.50 per share (subject to customary adjustments).
• Sponsor increased its monthly Trust Account loan contribution to $100,000 per month beginning April 30, 2026, through the earlier of liquidation and the Extended Date.
• The Company extended the deadline for public shareholders to reverse previously submitted redemption requests to May 1, 2026 at 5:00 p.m. ET.

Why It Matters
These actions provide the SPAC with additional runway and working capital to pursue an initial business combination by moving sponsor funds into the company and adjusting existing sponsor loans. The extension note and increased monthly sponsor contributions reduce near‑term cash pressure but create sponsor‑backed obligations and potential future dilution (through the sponsor’s conversion option into warrants). Public shareholders who submitted redemption requests were given additional time to rescind those requests, which could affect the number of shares redeemed and the cash available in the Trust Account.